96 related articles for article (PubMed ID: 9010618)
1. Cytotoxic quinolines (Part 3). Synthesis of 1-azolylalkyl-4(1H)-quinolones as cytotoxic agents.
Abel MD; Micetich RG; Nukatsuka M; Oreski AB; Tempest ML; Daneshtalab M
Drug Des Discov; 1996 Oct; 14(2):115-27. PubMed ID: 9010618
[TBL] [Abstract][Full Text] [Related]
2. Cytotoxic quinolines (part 1). Azolylalkyloxy quinolines and 1-azolylalkyl-4(1H)-quinolones.
Abel MD; Ha CM; Luu HT; Micetich RG; Nguyen DQ; Nukatsuka M; Oreski AB; Tempest ML; Daneshtalab M
Drug Des Discov; 1996 Mar; 14(1):15-30. PubMed ID: 8854042
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and antitumour activities of tetracyclic quinolone antineoplastic agents.
Chu DT; Hallas R; Tanaka SK; Alder J; Balli D; Plattner JJ
Drugs Exp Clin Res; 1994; 20(5):177-83. PubMed ID: 7875053
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and antitumor properties of N-[2-(dimethylamino)ethyl]carboxamide derivatives of fused tetracyclic quinolines and quinoxalines: a new class of putative topoisomerase inhibitors.
Deady LW; Kaye AJ; Finlay GJ; Baguley BC; Denny WA
J Med Chem; 1997 Jun; 40(13):2040-6. PubMed ID: 9207945
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and antitumour activities of quinolone antineoplastic agents.
Chu DT; Hallas R; Clement JJ; Alder J; McDonald E; Plattner JJ
Drugs Exp Clin Res; 1992; 18(7):275-82. PubMed ID: 1338309
[TBL] [Abstract][Full Text] [Related]
6. Design and synthesis of modified quinolones as antitumoral acridones.
Tabarrini O; Cecchetti V; Fravolini A; Nocentini G; Barzi A; Sabatini S; Miao H; Sissi C
J Med Chem; 1999 Jun; 42(12):2136-44. PubMed ID: 10377219
[TBL] [Abstract][Full Text] [Related]
7. Cytotoxic quinolines (part 2). Azolylalkylamino and-thio quinolines.
Abel MD; Ha CM; Luu HT; Micetich RG; Nguyen DQ; Nukatsuka M; Oreski AB; Tempest ML; Daneshtalab M
Drug Des Discov; 1996 Mar; 14(1):31-42. PubMed ID: 8854043
[TBL] [Abstract][Full Text] [Related]
8. In vitro cytotoxic activity of naphtho[1,2-b]furan, furo[2,3-f], furo[2,3-g] and furo[3,2-g]quinoline derivatives.
Nebois P; Cherkaoui O; Benameur L; Boitard M; Bartoli MH; Fillion H
Pharmazie; 1999 Mar; 54(3):215-8. PubMed ID: 10192109
[TBL] [Abstract][Full Text] [Related]
9. Functionalized N(2-oxyiminoethyl) piperazinyl quinolones as new cytotoxic agents.
Rajabalian S; Foroumadi A; Shafiee A; Emami S
J Pharm Pharm Sci; 2007; 10(2):153-8. PubMed ID: 17706174
[TBL] [Abstract][Full Text] [Related]
10. Synthesis and antitumor activity of the hexacyclic camptothecin derivatives.
Gao H; Zhang X; Chen Y; Shen H; Pang T; Sun J; Xu C; Ding J; Li C; Lu W
Bioorg Med Chem Lett; 2005 Jul; 15(13):3233-6. PubMed ID: 15913996
[TBL] [Abstract][Full Text] [Related]
11. Pyrimido[4,5-c]quinolin-1(2H)-ones as a novel class of antimitotic agents: Synthesis and in vitro cytotoxic activity.
Metwally K; Pratsinis H; Kletsas D
Eur J Med Chem; 2007 Mar; 42(3):344-50. PubMed ID: 17141923
[TBL] [Abstract][Full Text] [Related]
12. Novel brominated quinoline and pyrimidoquinoline derivatives as potential cytotoxic agents with synergistic effects of γ-radiation.
Ghorab MM; Ragab FA; Heiba HI; Nissan YM; Ghorab WM
Arch Pharm Res; 2012 Aug; 35(8):1335-46. PubMed ID: 22941476
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and cytotoxic properties of 4,11-bis[(aminoethyl)amino]anthra[2,3-b]thiophene-5,10-diones, novel analogues of antitumor anthracene-9,10-diones.
Shchekotikhin AE; Glazunova VA; Dezhenkova LG; Luzikov YN; Sinkevich YB; Kovalenko LV; Buyanov VN; Balzarini J; Huang FC; Lin JJ; Huang HS; Shtil AA; Preobrazhenskaya MN
Bioorg Med Chem; 2009 Mar; 17(5):1861-9. PubMed ID: 19208482
[TBL] [Abstract][Full Text] [Related]
14. Antitumor agents. 181. Synthesis and biological evaluation of 6,7,2',3',4'-substituted-1,2,3,4-tetrahydro-2-phenyl-4-quinolones as a new class of antimitotic antitumor agents.
Xia Y; Yang ZY; Xia P; Bastow KF; Tachibana Y; Kuo SC; Hamel E; Hackl T; Lee KH
J Med Chem; 1998 Mar; 41(7):1155-62. PubMed ID: 9544215
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity relationships for substituted bis(acridine-4-carboxamides): a new class of anticancer agents.
Gamage SA; Spicer JA; Atwell GJ; Finlay GJ; Baguley BC; Denny WA
J Med Chem; 1999 Jul; 42(13):2383-93. PubMed ID: 10395479
[TBL] [Abstract][Full Text] [Related]
16. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities.
Bailly C; Qu X; Chaires JB; Colson P; Houssier C; Ohkubo M; Nishimura S; Yoshinari T
J Med Chem; 1999 Jul; 42(15):2927-35. PubMed ID: 10425102
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antitumor activity of 4-aminomethylthioxanthenone and 5-aminomethylbenzothiopyranoindazole derivatives.
Perni RB; Wentland MP; Huang JI; Powles RG; Aldous S; Klingbeil KM; Peverly AD; Robinson RG; Corbett TH; Jones JL; Mattes KC; Rake JB; Coughlin SA
J Med Chem; 1998 Sep; 41(19):3645-54. PubMed ID: 9733489
[TBL] [Abstract][Full Text] [Related]
18. Antituberculosis agents IV: in vitro antimycobacterial activity and cytotoxicity of N-piperazinyl quinolone derivatives containing 2-thienyl and 2-furyl moiety.
Foroumadi A; Soltani F; Mirzaei M
Pharmazie; 2003 May; 58(5):347-8. PubMed ID: 12779054
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and anticancer activity of simplified indenoisoquinoline topoisomerase I inhibitors lacking substituents on the aromatic rings.
Nagarajan M; Morrell A; Fort BC; Meckley MR; Antony S; Kohlhagen G; Pommier Y; Cushman M
J Med Chem; 2004 Nov; 47(23):5651-61. PubMed ID: 15509164
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and antitumor characterization of pyrazolic analogues of the marine pyrroloquinoline alkaloids: wakayin and tsitsikammamines.
Legentil L; Benel L; Bertrand V; Lesur B; Delfourne E
J Med Chem; 2006 May; 49(10):2979-88. PubMed ID: 16686539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
